Study Description
ONCODIR (Evidence-based Participatory Decision Making for Cancer Prevention through implementation) will identify risk factors associated with colorectal cancer (CRC) and will integrate multidisciplinary research methods and technologies (including health policy analytics, artificial intelligence, and decision support theories) to deliver evidence-based and personalized recommendations on colorectal cancer prevention.
Study Details
- Type: HORIZON-RIA, HORIZON-MISS-2022-CANCER-01-01
- Start: 1/6/2023
- End: 1/11/2026
- Duration: 42 months
Our Role
Innovation Sprint will be offering Healthentia for use by healthy citizens to collect data for CRC prevention. Healthentia will be offering advice on citizens’ behavior, based on the collected data and the resulting citizen understanding.
To that extend, Healthentia will be extended both in terms of functionality and content. The new functionality involves:
(1) the development of a new biomarker widget to display risk prediction results automatically collected from other modules of ONCODIR.
(2) the creation of a Kafka client, producing towards, and consuming from ONCODIR, to facilitate integration with the rest of the project.
(3) the introduction of a mechanism to wrap recommendation messages into a dialogue, facilitating both delivery and feedback towards clinicians and policy makers.
In terms of content, CRC-related questionnaires will be facilitated, and a dialogue for recommendation wrapping will be created. The resulting solution will be tested in terms of technology readiness in Laboratory Integration Test 2 and will be delivered to the large-scale pilots for use by the citizens.
